These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36522654)

  • 1. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
    Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
    BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the molecular landscape: a comparative analysis of PI3K and MAPK signaling pathways in plasmablastic lymphoma and diffuse large B-cell lymphoma with therapeutic implications.
    Mansoor A; Akhter A; Kamran H; Minoo P; Stewart D
    Hum Pathol; 2023 Nov; 141():102-109. PubMed ID: 37524252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmablastic lymphoma: current knowledge and future directions.
    Li JW; Peng HL; Zhou XY; Wang JJ
    Front Immunol; 2024; 15():1354604. PubMed ID: 38415257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways.
    Mansoor A; Kamran H; Akhter A; Seno R; Torlakovic EE; Roshan TM; Shabani-Rad MT; Elyamany G; Minoo P; Stewart D
    Mod Pathol; 2023 Aug; 36(8):100198. PubMed ID: 37105495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature.
    Fu Z; Wang H; Lauwers GY; Jiang K; Jayaratne NL; Bridglal S; Dong N; Wang E; Chen L; Barclift DP; Zhang L
    Ann Diagn Pathol; 2023 Dec; 67():152204. PubMed ID: 37639839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
    Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
    Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the archives of MD Anderson Cancer Center: Plasmablastic lymphoma presenting as a kidney mass in an immunocompetent patient: Case report and literature review.
    Gietzen R; Muthukumarana V; Bhargava P; Vozniuk D; Thakral B; Medeiros LJ; Lyapichev KA
    Ann Diagn Pathol; 2023 Dec; 67():152186. PubMed ID: 37541853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic analysis of HIV-negative plasmablastic lymphoma].
    Chen Y; Liu Y; Luo D; Zhang F; Xu F; Ge Y; Luo X; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):548-52. PubMed ID: 26705177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
    Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
    Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmablastic Lymphoma Presenting as Extensive Peritoneal and Retroperitoneal Nodules in an HIV-Positive Patient.
    Pokhrel A; Yuldasheva O; Mirashi E; Nair K; Salyana M; Jaswani V; Avezbakiyev B; Wang JC
    J Investig Med High Impact Case Rep; 2022; 10():23247096211065633. PubMed ID: 35073776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
    Witte HM; Künstner A; Hertel N; Bernd HW; Bernard V; Stölting S; Merz H; von Bubnoff N; Busch H; Feller AC; Gebauer N
    Blood Adv; 2022 Jan; 6(2):637-651. PubMed ID: 34714908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasmablastic lymphoma].
    Fernández-Álvarez R; Sancho JM; Ribera JM
    Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmablastic lymphoma: Review of 60 Chinese cases and prognosis analysis.
    Han X; Duan M; Hu L; Zhou D; Zhang W
    Medicine (Baltimore); 2017 Mar; 96(9):e5981. PubMed ID: 28248855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
    Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
    Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.
    Liu M; Liu B; Liu B; Wang Q; Ding L; Xia C; Dong L
    Oncol Rep; 2015 Apr; 33(4):1615-20. PubMed ID: 25695332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
    Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
    Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmablastic lymphoma: from genetics to treatment.
    Frontzek F; Hailfinger S; Lenz G
    Leuk Lymphoma; 2023 Apr; 64(4):799-807. PubMed ID: 36577021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
    Di Ciaccio PR; Polizzotto MN; Cwynarski K; Gerrie AS; Burton C; Bower M; Kuruvilla J; Montoto S; McKay P; Fox CP; Milliken S; Jiamsakul A; Osborne W; Collins GP; Manos K; Linton KM; Iyengar S; Kassam S; Limei MP; Kliman D; Wong Doo N; Watson AM; Fedele P; Yannakou CK; Hunt S; Ku M; Sehn LH; Smith A; Renshaw H; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Painter D; Thakrar N; Song KW; Hamad N
    Blood; 2024 Jan; 143(2):152-165. PubMed ID: 37832030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3-positive plasmablastic lymphoma reported in two cases: A potential diagnostic caveat.
    Wong YP; Masir N; Chew MX
    Indian J Pathol Microbiol; 2021; 64(3):579-583. PubMed ID: 34341278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.